As many as 80 employees of drug major Sun Pharmaceuticals were laid off after the company suspended its operations at two clinical units in Gujarat’s Vadodara citing cost efficiency as the reason behind the sacking. The terminated employees were not given any intimation regarding the suspension and were immediately asked to leave the company.
According to a report by Livemint, the employees were only given three month’s salary after the termination. However, the officials from Sun Pharma denied such reports and claimed that they provided full support to the employees.
The company is planning to shut down two more clinical units at Tandalja and Akota, in order to ensure optimal utilization of clinical pharmacology units (CPUs)
Commenting on the issue, a worker at Sun Pharmaceuticals Industries said, “While we continue to make investments in our R&D operations, we also constantly evaluate our resources and future capacity requirements to bring in efficiencies in cost and processes.”
Furthermore, he added that the company is planning to shut down two more clinical units at Tandalja and Akota, in order to ensure optimal utilization of clinical pharmacology units (CPUs) that conduct bio-equivalence studies.
The major R&D centers of Sun Pharmaceuticals are located at Gurgaon, Mumbai, Vadodara, Haifa (Israel), Brampton (Canada) and New Jersey (The US).